Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Watton Corey Michael sold 12,300 Zevra Therapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Watton Corey Michael (Director) sold 12,300 Zevra Therapeutics, Inc. shares at US$11.25 for US$138K, leaving 1,800 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 12,300 shares
- Price
- US$11.25
- Value
- US$138K
- Holding after
- 1,800 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Option exercise | 12,300 | US$4.97 | 14,100 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 12,300 | US$11.25 | 1,800 | Direct |
Source
Related
- Zevra Therapeutics, Inc.
- Watton Corey Michael
- Zevra Therapeutics, Inc. shareholders
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026